Johnson & Johnson has been fined by a US court for its marketing of Risperdal. Photograph: JB Reed/Bloomberg

A Philadelphia jury on Tuesday hit Johnson & Johnson with an $8 billion verdict over its marketing of the anti-psychotic drug Risperdal, siding wi(...)